TimesSquare Capital Management’s Legend Biotech LEGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,912	Closed	-$94.8K	–	153
2024 Q4	$94.8K	Sell	2,912 -1,156,518	-100%	-$47.9M	﹤0.01%	150
2024 Q3	$56.5M	Sell	1,159,430 -14,336	-1%	-$764K	0.85%	44
2024 Q2	$52M	Buy	1,173,766 +15,266	+1%	+$704K	0.82%	46
2024 Q1	$65M	Buy	1,158,500 +92,611	+9%	+$5.58M	0.94%	37
2023 Q4	$64.1M	Buy	1,065,889 +142,118	+15%	+$9.01M	0.94%	38
2023 Q3	$62M	Buy	923,771 +4,779	+0.5%	+$332K	0.97%	34
2023 Q2	$63.4M	Sell	918,992 -144,618	-14%	-$9.45M	0.91%	40
2023 Q1	$51.3M	Buy	1,063,610 +117,110	+12%	+$5.73M	0.75%	52
2022 Q4	$47.2M	Buy	946,500 +5,200	+0.6%	+$252K	0.67%	63
2022 Q3	$38.4M	Buy	941,300 +849,800	+929%	+$39.9M	0.53%	88
2022 Q2	$5.03M	Buy	91,500 +5,500	+6%	+$232K	0.07%	172
2022 Q1	$3.13M	Buy	+86,000	New	+$3.4M	0.04%	193
2020 Q3	–	Sell	-134,100	Closed	-$5.71M	–	241
2020 Q2	$5.71M	Buy	+134,100	New	+$5.24M	0.05%	203